Heart health

This trial did not find evidence that Buteyko breathing improved sleep quality, fatigue or oxygen saturation more than diaphragmatic breathing in people with acute coronary syndrome. Both groups received routine care and improved over time. Those within-group improvements cannot show that Buteyko breathing caused the changes or added a specific benefit.

Keep in mind: The abstract lists 92 adults in its methods but 90 randomized patients in its results. It also does not show whether changes persisted beyond the intervention.

The pooled trials found lower major bleeding risk but higher stroke risk with Factor XI/XIa inhibitors than with direct oral anticoagulants. Systemic embolism risk was also higher; mortality differences were not statistically significant. Lower bleeding risk alone therefore cannot establish a better overall treatment strategy for people with atrial fibrillation.

Keep in mind: The abstract omits follow-up durations and absolute event rates. These pooled results do not establish the best individual drug or dose.

The review found differences in the composition, blood-vessel supply and metabolic markers of thigh muscle in people with heart failure. However, absolute muscle fiber areas were described as similar between groups. These tissue measurements characterize an association with heart failure; they do not establish its cause or show that a particular treatment improves physical function.

Keep in mind: This abstract-based summary concerns cross-sectional tissue differences, so it cannot establish which changes came first. The abstract reports no intervention results or measures of participants' physical function.

The review reported higher circulating PCSK9 following conventional lipid-lowering treatment. That is a laboratory finding, and the abstract does not say whether participants experienced more or fewer cardiovascular events. Although the authors recommend monitoring this protein, the reported results do not establish that monitoring would improve patient outcomes or guide a beneficial treatment change.

Keep in mind: The methods name standardized mean differences, while the results report a weighted mean difference. The abstract also leaves the pooled comparator unclear, limiting interpretation of the estimate in this abstract-based summary.

These blinded trials supported few additional side effects attributed to statins on product labels. They found increases in liver-test abnormalities, urine composition changes and swelling, separately from previously reported muscle and diabetes effects. Most other listed conditions lacked support for a causal link, although this does not prove that individual reactions are impossible.

Keep in mind: The abstract does not detail every condition assessed or the clinical consequences of abnormal liver tests. This brief cannot evaluate those missing details.

Higher fine-particle exposure was associated with higher systolic blood pressure in this review of young adults in Asia. The overall diastolic estimate included no association within its confidence interval, so that result remains uncertain. These associations do not establish that pollution caused the differences or quantify heart disease risk.

Keep in mind: The evidence mainly applies to East Asia. The abstract does not detail exposure windows or adjustment for other influences, limiting interpretation of causality and applicability elsewhere.

In the pooled trials, music groups had lower blood pressure, heart rate, anxiety scores and depression scores than comparison groups. The abstract does not specify what those groups received or how long outcomes were tracked. These results therefore leave uncertainty about how music was used and whether the differences persisted.

Keep in mind: The abstract omits intervention schedules, comparator treatments and follow-up durations. It does not report whether blood-pressure differences translated into fewer cardiovascular events.

The pooled observational studies did not establish lower mortality or fewer heart-failure hospitalizations with sacubitril/valsartan. In the end-stage kidney disease subgroup, the drug was associated with better heart-pumping measurements and lower systolic blood pressure. Those findings do not establish a survival benefit, and observational associations cannot demonstrate treatment effects.

Keep in mind: The abstract omits comparator treatments and follow-up durations. Its imprecise estimates leave clinical benefit uncertain, and observational safety findings cannot confirm an absence of risk.

According to the abstract, adding liraglutide to metformin reduced several circulating vesicle measures. Empagliflozin and gliclazide showed no statistically significant changes. The reported lack of change in leukocyte-derived vesicles across groups does not exclude an effect. These exploratory markers do not establish fewer vascular complications or show that liraglutide outperformed the other treatments.

Keep in mind: The abstract reports exploratory markers, without clinical vascular outcomes or confidence intervals for marker changes. Those omissions limit conclusions about vascular health and the reported null findings.

In this review's abstract, aerobic exercise was the only non-drug approach with statistically significant estimates for both anxiety and depression in people with heart failure. However, the evidence was rated low to very low certainty. The results suggest a possible benefit while leaving substantial uncertainty about its size and which approach works best.

Keep in mind: The abstract rates certainty as low to very low and omits the reference comparator and follow-up duration. It does not support confident treatment rankings or conclusions about longer-term symptom changes.

Across the included trials, sodium nitrate did not significantly lower systolic or diastolic blood pressure compared with placebo. Resting heart rate also showed no significant reduction. The estimates remain uncertain: their confidence intervals allow for lower or higher values. These results establish neither a blood pressure benefit nor equivalence to placebo.

Keep in mind: Only a small number of trials were available. This abstract-based assessment cannot resolve longer-term effects because individual study durations and results by duration are not provided.

In animal experiments, estrogen and progesterone showed favorable effects after ischemic stroke across the measures analyzed. Testosterone showed mostly null results. Findings after hemorrhagic stroke were less consistent and based on fewer studies. This abstract-based review offers a direction for further animal research, without establishing that hormone treatment benefits people after stroke.

Keep in mind: Evidence certainty ranged from very low to moderate. The authors attributed uncertainty to limited scientific rigor and weaknesses affecting translation to humans; animal results cannot establish clinical effectiveness.

Higher starting testosterone was linked to lower cardiovascular risk in men. Associations involving estradiol and a hormone-binding protein were reported in particular weight-loss subgroups. No associations were detected in women. These observational findings do not establish that changing hormone levels would prevent events, or that associations truly differ by sex.

Keep in mind: This abstract-based account lacks cardiovascular follow-up length and adjustment details. Subgroup findings alone cannot establish that weight loss changes the hormone–event association.

The review describes changes in heart rate variability during sustained workloads, including changes appearing before performance declined or symptoms emerged. These observations suggest a possible monitoring role in demanding environments. However, the abstract does not establish how accurately an individual warning predicts exhaustion, or whether acting on such warnings improves health or performance.

Keep in mind: The abstract provides no study count, pooled effects, prediction accuracy, or detailed quality assessment. Its broad conclusions about monitoring cannot establish the reliability of a particular device or algorithm.

The review found an overall association between clinical risk factors and stroke outcomes, alongside reports of psychosocial influences. Because the abstract does not name the pooled outcome or reference groups, the combined result cannot be translated into a specific recovery probability. It also does not show that changing any factor improves recovery.

Keep in mind: This abstract-based account lacks follow-up periods, comparator definitions and a named pooled outcome. The combined estimate cannot separate each factor's contribution or describe an individual survivor's prognosis.

In this abstract-based review, randomized trials did not show a clear advantage of video over direct laryngoscopy for initial or overall tube-placement success during cardiac arrest. Observational studies generally favored video for placement, but did not consistently link it to better survival. These findings establish neither equivalent performance nor improved patient outcomes.

Keep in mind: Evidence certainty was very low. Observational associations cannot establish causation, and the abstract cannot explain why study designs gave different results. Trial estimates remain compatible with different effects.

Some manikin studies associated kneeling with more effective or efficient chest compressions than standing. Evidence about height was limited, and hand-position changes appeared to make little difference. Because these were weak observational studies using manikins, the review cannot establish improved survival or provide a firm basis for changing emergency practice.

Keep in mind: Every included study used manikins and was rated weak overall. The abstract does not report pooled effect sizes, detailed performance measures or study durations, limiting interpretation beyond simulated compression performance.

Among people with established cardiovascular disease, higher Mediterranean diet adherence was linked to fewer major cardiovascular events and deaths. Both randomized trials and cohort studies favored higher adherence, although their estimates differed. The review did not find statistically clear improvements in blood pressure, blood lipids or body composition, and evidence certainty varied across outcomes.

Keep in mind: The abstract does not describe the comparison diets, follow-up periods or how adherence was scored. It also does not identify which outcomes had stronger evidence, limiting interpretation of the pooled results.

The trial tested structured music listening during care for patients undergoing PCI. Its abstract reports reduced pain and anxiety among music recipients after the procedure, alongside lower pain-medication requirements and greater nursing-care satisfaction. However, the results do not specify whether these describe changes from baseline or differences from the routine-care group.

Keep in mind: The abstract leaves the result comparator unresolved and gives no effect sizes, confidence intervals or significance tests. It also omits listening duration and complication counts, limiting assessment of benefit and safety.

Participants assigned to the remote program improved more on the walking test than those receiving conventional offline guidance. The program also showed favorable changes in systolic blood pressure and several exercise-related measures. These results support a short-term benefit of the combined program in the studied patients, while leaving its durability and the specific contribution of AI unresolved.

Keep in mind: The trial was open-label and used convenience sampling. Reported differences lack explicit units in the abstract, and the short follow-up does not establish lasting benefits or effects on cardiovascular events.

Among people with heart failure and iron deficiency, ferric carboxymaltose reduced the combined risk of hospitalization for heart failure or cardiovascular death compared with controls. The separate hospitalization and mortality analyses were not statistically significant. This supports a benefit on the combined outcome, while leaving uncertain whether treatment reduces deaths or hospitalizations considered individually.

Keep in mind: This abstract-based summary cannot assess absolute benefit or detailed safety: event rates, follow-up durations and safety results were not provided. Those omissions limit interpretation of the treatment's practical impact.

The clearest finding was greater left-ventricular mass relative to body weight, alongside larger heart muscle cells. Evidence for impaired pumping function was less certain. These animal results help explain possible biological links between disrupted daily rhythms and heart changes, but they do not measure cardiovascular risk in human shift workers.

Keep in mind: The evidence comes from animal models, and the abstract leaves exposure durations and comparison conditions unspecified. Human shift workers remain an evidence gap, so these results cannot quantify their health risks.

Adding tirofiban or eptifibatide to intravenous thrombolysis did not clearly improve functional independence after acute ischemic stroke overall. Mortality and bleeding comparisons were also inconclusive. Randomized tirofiban trials suggested a possible benefit for independence, but that signal remained uncertain and needs confirmation in larger trials.

Keep in mind: The main analysis combined randomized and observational studies. The abstract provides no estimate for the tirofiban-only randomized analysis, limiting assessment of that possible benefit.

Adding Yuxintong to conventional treatment improved anaerobic threshold, a fitness measure based on oxygen uptake during exercise. However, peak oxygen uptake showed no statistically significant advantage over placebo. General health and vitality questionnaire scores improved. These mixed results do not establish a broad improvement in heart health or lasting benefit.

Keep in mind: The abstract does not explain why fewer participants were analyzed than randomized. It provides limited safety details and no results beyond the treatment period, restricting conclusions about longer-term effects.